Vicković Lab

The Vicković Lab is focused on developing novel “digital pathology” tools to track disease progression with the aim of identifying translatable drug and therapeutic targets in human tissue cohorts. The team leverages technologies including spatial transcriptomics, single-cell sequencing, and machine learning. A particular area of disease focus for the lab is developing tools for spatial genomics that will enable perturbing highly complex interactions in the human gut.

The team is studying why inflammation in the bowel increases the risk of cancer and what happens to our gut during aging.

Sanja Vicković, PhD

Sanja Vicković, PhD, is a Core Faculty Member and Director, Technology Innovation Lab, at the New York Genome Center. She holds joint appointments as an Assistant Professor at the Fu Foundation School of Engineering and Applied Science and the Herbert and Florence Irving Institute for Cancer Dynamics at Columbia University, and as a Wallenberg Academy Fellow of the Royal Swedish Academy of Sciences and the Royal Swedish Academy of Engineering Sciences at Uppsala University.

Dr. Vicković is an experienced and accomplished engineer and an inventor of the spatial transcriptomic technology called “Visium” and now commercialized by 10x Genomics. In addition to being a skilled technologist, Dr. Vicković also has training and experience in mathematics and biological sciences. Prior to joining the NYGC in 2022, Dr. Vicković had already collaborated with the NYGC, playing a crucial role in the first demonstration of the application of spatial transcriptomics to a disease model in collaboration with researchers at the NYGC’s Center for Genomics of Neurodegenerative Disease.

Dr. Vicković joined the NYGC from the Broad Institute of MIT and Harvard, where she was a Wallenberg Fellow in Aviv Regev’s lab. She obtained her PhD in Gene Technology from the KTH Royal Institute of Technology, Stockholm.